Target Firm Material Contract Redactions and Valuation in Acquisitions
The Accounting Review · 01.11.2026 · 1-28
DOI: 10.2308/tar-2023-0169 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Accounting Review, online erschienen am 19.11.2026. Verfasst von Paul A. Griffin und 3 weiteren Autor:innen.
Abstract (Originalsprache)
We study whether and how the SEC’s confidential treatment program, which allows firms to redact proprietary information from material contracts, affects valuation in corporate acquisitions. We find that friendly acquisitions of redacting targets generate significantly higher positive announcement returns for both targets and acquirers compared with acquisitions of nonredacting targets. These positive returns are also more pronounced when targets are likelier to hold valuable proprietary information. In addition, friendly acquisitions of redacting targets achieve better long-term performance and recognize fewer subsequent goodwill impairments compared with acquisitions of nonredacting targets. Our findings of a robust association between target firm material contract redactions and target and acquirer announcement returns are consistent with a dual disclosure perspective, whereby redaction preserves target proprietary value, which is transferred privately to the acquirer through due diligence. Data Availability: Data are available from public sources identified in the paper; some require a subscription. JEL Classifications: D8; M41; M48.
Zitieren
APA
Griffin, P. A., Hong, H. A., Lee, K., & Ryou, J. (2026). Target Firm Material Contract Redactions and Valuation in Acquisitions. The Accounting Review, 1-28. https://doi.org/10.2308/tar-2023-0169
Vancouver
Griffin PA, Hong HA, Lee K, Ryou J. Target Firm Material Contract Redactions and Valuation in Acquisitions. The Accounting Review. 2026:1-28. doi:10.2308/tar-2023-0169
BibTeX
@article{Griffin2026,
author = {Griffin, Paul A. and Hong, Hyun A. and Lee, Kyungran and Ryou, Jiwoo},
title = {Target Firm Material Contract Redactions and Valuation in Acquisitions},
journal = {The Accounting Review},
year = {2026},
pages = {1--28},
doi = {10.2308/tar-2023-0169}
}
EUVIMED